Gengwei Huo
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 29, 2025
Adagrasib in the treatment of KRASG12C-mutated non-small cell lung cancer: a cost-effectiveness analysis.Gengwei Huo, Ying Song, Shenge Liu
|May 13, 2024
Entrectinib as first-line vs. second-line therapy in ROS1 fusion-positive non-small cell lung cancer: a cost-effectiveness analysis.Gengwei Huo, Ying Song, Xiongwen Chen
|Apr 12, 2024
Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer.Gengwei Huo, Ying Song, Peng Chen
|Apr 12, 2024
Cost-effectiveness of atezolizumab plus chemotherapy for advanced/recurrent endometrial cancer.Gengwei Huo, Ying Song, Peng Chen
|Feb 08, 2024
Cost-effectiveness of tisotumab vedotin as a second- or third-line therapy for cervical cancer.Gengwei Huo, Wenjie Liu, Peng Chen
Pageof 1